Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial
Authors:
- Jone TrovikJTJone Trovik
- Elisabeth WikEWElisabeth Wik
- Henrica M.J. WernerHWHenrica M.J. Werner
- Camilla KrakstadCKCamilla Krakstad
- Harald HellandHHHarald Helland
- Ingrid VandenputIVIngrid Vandenput
- Tormund S. NjolstadTNTormund S. Njolstad
- Ingunn M. StefanssonISIngunn M. Stefansson
- Janusz MarcickiewiczJMJanusz Marcickiewicz
- Solveig TingulstadSTSolveig Tingulstad
- Anne C. StaffASAnne C. Staff
- Frederic AmantFAFrederic Amant
Open Access
- 1 November 2013
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 49 (16) , 3431-3441
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Accuracy of intraoperative gross visual assessment of myometrial invasion in endometrial cancerActa Obstetricia et Gynecologica Scandinavica, 2011
- Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial CancerClinical Cancer Research, 2011
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activationProceedings of the National Academy of Sciences, 2009
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Endometrial cancer: can nodal status be predicted with curettage?Gynecologic Oncology, 2005
- Predictors of final histology in patients with endometrial cancerGynecologic Oncology, 2004
- High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapyGynecologic Oncology, 2004
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998